eFFECTOR Therapeutics, Inc.

eFFECTOR Therapeutics, Inc.

EFTR
eFFECTOR Therapeutics, Inc.US flagOther OTC
0.00
USD
+0.00
- -
2,352.00Market Cap

Income Statement (USD)

APIChatGPT
2020 Y
2021 Y
2022 Y
2023 Y
As of date
12/31/2020
12/31/2021
12/31/2022
12/31/2023
Sales/Revenue/Turnover
42
- -
- -
- -
+ Sales & Services Revenue
42
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
+ Other Operating Income
-42
- -
- -
- -
- Operating Expenses
26
32
32
34
+ Selling, General & Admin
4
13
13
11
+ Research & Development
22
20
23
23
+ Other Operating Expense
- -
-1
-4
- -
Operating Income (Loss)
16
-32
-32
-34
- Non-Operating (Income) Loss
1
-48
-10
2
+ Interest Expense, Net
1
2
2
2
+ Interest Expense
1
2
2
3
- Interest Income
- -
- -
- -
1
+ Other Non-Op (Income) Loss
- -
-49
-12
- -
Pretax Income
15
16
-23
-36
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
Income (Loss) from Cont Ops
14
16
-23
-36
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
Income (Loss) Incl. MI
14
16
-23
-36
- Minority Interest
- -
- -
- -
- -
Net Income, GAAP
14
16
-23
-36
- Preferred Dividends
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
Net Income Avail to Common, GAAP
14
16
-23
-36
EBIT
16
-32
-32
-34
EBITDA
16
-32
-32
-34
EBITDA Margin (%)
38.05
- -
- -
- -
EBITA
16
-32
-32
-34
Gross Margin (%)
100
- -
- -
- -
Operating Margin (%)
37.66
- -
- -
- -
Profit Margin (%)
33.84
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
Basic Weighted Avg Shares
2
1
2
2
Basic EPS, GAAP
8.8
26.15
-13.76
-16.37
Basic EPS from Cont Ops
8.8
26.15
-13.76
-16.37
Diluted Weighted Avg Shares
2
1
2
2
Diluted EPS, GAAP
8.8
10.97
-13.76
-16.37
Diluted EPS from Cont Ops
8.8
10.97
-13.76
-16.37

Balance Sheet (USD)

APIChatGPT
2020 Y
2021 Y
2022 Y
2023 Y
As of date
12/31/2020
12/31/2021
12/31/2022
12/31/2023
Total Current Assets
17
53
28
20
+ Cash, Cash Equivalents & STI
15
50
26
18
+ Cash & Cash Equivalents
15
50
9
15
+ ST Investments
- -
- -
18
3
+ Accounts & Notes Receiv
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
+ Other ST Assets
1
3
2
1
+ Misc ST Assets
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
Total Noncurrent Assets
- -
1
1
1
+ Property, Plant & Equip, Net
- -
- -
- -
- -
+ Property, Plant & Equip
- -
- -
1
1
- Accumulated Depreciation
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
+ Other LT Assets
- -
1
1
1
+ Total Intangible Assets
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
+ Misc LT Assets
- -
1
1
1
Total Assets
17
54
29
21
+ Payables & Accruals
2
3
3
4
+ Accounts Payable
- -
1
1
2
+ Accrued Taxes
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
+ Other Payables & Accruals
1
2
2
1
+ ST Debt
6
- -
20
21
+ ST Borrowings
6
- -
20
20
+ ST Finance Leases
- -
- -
- -
- -
+ Other ST Liabilities
1
1
1
2
+ Deferred Revenue
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Misc ST Liabilities
1
1
1
2
Total Current Liabilities
9
4
25
26
+ LT Debt
7
20
- -
- -
+ LT Borrowings
7
20
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
+ Other LT Liabilities
133
13
- -
1
+ Accrued Liabilities
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
+ Misc LT Liabilities
133
13
- -
1
Total Noncurrent Liabilities
140
33
- -
1
Total Liabilities
149
37
25
26
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
+ Share Capital & APIC
4
138
147
174
+ Common Stock
- -
- -
- -
- -
+ Additional Paid in Capital
4
138
147
174
- Treasury Stock
- -
- -
- -
- -
+ Retained Earnings
-137
-121
-144
-179
+ Other Equity
- -
- -
- -
- -
Equity Before Minority Interest
-132
17
4
-6
+ Minority/Non Controlling Interest
- -
- -
- -
- -
Total Equity
-132
17
4
-6
Total Liabilities & Equity
17
54
29
21
Shares Outstanding
2
2
2
3
Number of Employees
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
Net Debt
-2
-30
11
6
Net Debt to Equity
1.79
-172.66
293.97
-96.81
Tangible Common Equity Ratio
-791.7
31.97
13.4
-28.21
Current Ratio
1.89
13.3
1.12
0.77
Cash Conversion Cycle
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2020 Y
2021 Y
2022 Y
2023 Y
As of date
12/31/2020
12/31/2021
12/31/2022
12/31/2023
+ Net Income
14
16
-23
-36
+ Depreciation & Amortization
- -
- -
- -
- -
+ Non-Cash Items
- -
-40
-6
4
+ Stock-Based Compensation
- -
9
5
5
+ Deferred Income Taxes
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
-49
-11
- -
+ Chg in Non-Cash Work Cap
-1
- -
3
2
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
-1
2
1
+ Inc (Dec) in Accts Payable
-1
2
1
1
+ Inc (Dec) in Other
- -
-1
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Operating Activities
14
-25
-26
-30
+ Change in Fixed & Intang
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
1
- -
- -
+ Disp of Fixed Prod Assets
- -
1
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
3
21
+ Increase in Capital Stock
- -
- -
3
21
+ Decrease in Capital Stock
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
-18
15
+ Dec in LT Investment
- -
- -
35
32
+ Inc in LT Investment
- -
- -
-52
-17
+ Net Cash From Acq & Div
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Investing Activities
- -
1
-18
14
+ Dividends Paid
- -
- -
- -
- -
+ Net Cash From Debt
-2
6
- -
- -
+ Cash From Debt
- -
20
- -
- -
+ Repayments of Debt
-2
-14
- -
- -
+ Other Financing Activities
- -
53
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Financing Activities
-2
59
3
21
Effect of Foreign Exchange Rates
- -
- -
- -
- -
Net Changes in Cash
12
34
-41
6
EBITDA
16
-32
-32
-34
EBITDA Margin (%)
38.05
- -
- -
- -
Free Cash Flow
14
-25
-26
-30
Net Cash Paid for Acquisitions
- -
- -
- -
- -
Free Cash Flow to Firm
15
-23
- -
- -
Free Cash Flow to Equity
- -
-18
-26
-30
Free Cash Flow per Basic Share
8.47
-41.26
-15.84
-13.56
Price/Free Cash Flow
- -
-12
-0.68
-0.87
Cash Flow to Net Income
0.97
-1.58
1.14
0.83
Capital Expenditures
- -
- -
- -
- -